Unknown

Dataset Information

0

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.

ABSTRACT: The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3-23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins.

SUBMITTER: Haveri A 

PROVIDER: S-EPMC7096774 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.

Haveri Anu A   Smura Teemu T   Kuivanen Suvi S   Österlund Pamela P   Hepojoki Jussi J   Ikonen Niina N   Pitkäpaasi Marjaana M   Blomqvist Soile S   Rönkkö Esa E   Kantele Anu A   Strandin Tomas T   Kallio-Kokko Hannimari H   Mannonen Laura L   Lappalainen Maija M   Broas Markku M   Jiang Miao M   Siira Lotta L   Salminen Mika M   Puumalainen Taneli T   Sane Jussi J   Melin Merit M   Vapalahti Olli O   Savolainen-Kopra Carita C  

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20200301 11

The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3-23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid an  ...[more]

Similar Datasets

Unknown Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021.
| S-EPMC9838690 | biostudies-literature
Unknown SARS-CoV-2 Transmission Potential and Policy Changes in South Carolina, February 2020 - January 2021.
| S-EPMC9530385 | biostudies-literature
Unknown Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
| S-EPMC10789014 | biostudies-literature
Unknown Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26-February 16, 2021.
| S-EPMC8084510 | biostudies-literature
Unknown SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020.
| S-EPMC7392408 | biostudies-literature
Unknown Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland-Bayesian inference based on a series of serological surveys.
| S-EPMC10289354 | biostudies-literature
Unknown The phylodynamics of SARS-CoV-2 during 2020 in Finland.
| S-EPMC9187640 | biostudies-literature
Unknown Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.
| S-EPMC7258458 | biostudies-literature
Unknown First Cases of SARS-CoV-2 in Iran, 2020: Case Series Report.
| S-EPMC7554384 | biostudies-literature
Unknown Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020.
| S-EPMC7542927 | biostudies-literature